Drug Resistance in Oncology
1993
Drug Resistance in Oncology: A Book Review
publication
Author Information
Author(s): P.R. Twentyman
Conclusion
The book contains valuable information but suffers from a lack of focus and an inappropriate title.
Supporting Evidence
- The book contains 26 chapters by leading experts in oncology.
- Many chapters relate to radiation responsiveness, not just drug resistance.
- The book is expensive and may not appeal to individual buyers.
Takeaway
This book talks about how cancer cells resist treatments, but it could have been named better to reflect its content.
Potential Biases
Inconsistent reference systems and variable quality of illustrations may introduce bias.
Limitations
The book lacks a comprehensive account of clinical resistance and has variable quality in chapter presentations.
Want to read the original?
Access the complete publication on the publisher's website